Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Return on Assets: 2020-2025

Historic Return on Assets for Benitec Biopharma (BNTC) over the last 4 years, with Mar 2025 value amounting to -0.37%.

  • Benitec Biopharma's Return on Assets rose 81.00% to -0.37% in Q1 2025 from the same period last year, while for Mar 2025 it was -0.37%, marking a year-over-year increase of 81.00%. This contributed to the annual value of -0.76% for FY2024, which is 290.00% up from last year.
  • Latest data reveals that Benitec Biopharma reported Return on Assets of -0.37% as of Q1 2025, which was down 14.97% from -0.32% recorded in Q4 2024.
  • In the past 5 years, Benitec Biopharma's Return on Assets registered a high of -0.32% during Q4 2024, and its lowest value of -3.01% during Q2 2023.
  • Its 3-year average for Return on Assets is -1.11%, with a median of -0.90% in 2023.
  • In the last 5 years, Benitec Biopharma's Return on Assets tumbled by 145bps in 2022 and then surged by 237bps in 2024.
  • Over the past 5 years, Benitec Biopharma's Return on Assets (Quarterly) stood at -1.09% in 2021, then fell by 14bps to -1.23% in 2022, then soared by 33bps to -0.90% in 2023, then soared by 57bps to -0.32% in 2024, then skyrocketed by 81bps to -0.37% in 2025.
  • Its Return on Assets was -0.37% in Q1 2025, compared to -0.32% in Q4 2024 and -0.35% in Q3 2024.